BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/4/2020 3:58:07 AM | Browse: 271 | Download: 341
Category |
Medicine, Research & Experimental |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Wei Zhang, Yu-Long Tian, Qiao-Zheng Wang, Xiao-Wei Chen, Qi-Yang Li, Jin-Hang Han, Xu-Dong Chen and Ke Xu |
Funding Agency and Grant Number |
|
Corresponding Author |
Ke Xu, MD, PhD, Professor, Department of Interventional Radiology, The First Affiliated Hospital of China Medical University, 155 Nanjing Bei Street, Shenyang 110001, Liaoning Province, China. kexu@vip.sina.com |
Key Words |
Budd-Chiari syndrome; Restenosis; Long-term follow-up; Treatment strategy; ; |
Core Tip |
This is the first study to explore the treatment strategy for restenosis in Chinese patients with Budd-Chiari syndrome after interventional therapy and evaluate the outcomes with more than 20-year follow-up. The 1-, 5-, 10-, 20- and 25-year cumulative survival rates of the 38 patients who received further treatment after restenosis were 100%, 78.3%, 78.3%, 70.5% and 70.5%, respectively; however, for the 22 patients who refused treatment, the survival rates were 72.7%, 45.9%, 30.6%, 10.2% and unavailable, respectively (P < 0.001). Regular follow-up and active treatment can result in satisfactory prognosis in Budd-Chiari syndrome patients with restenosis. |
Citation |
Zhang W, Tian YL, Wang QZ, Chen XW, Li QY, Han JH, Chen XD, Xu K. Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients. World J Clin Cases 2020; 8(14): 2930-2941 |
|
Received |
|
2020-03-06 12:51 |
|
Peer-Review Started |
|
2020-03-06 12:52 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-15 01:58 |
|
Revised |
|
2020-06-03 12:22 |
|
Second Decision |
|
2020-07-01 10:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-07-04 03:58 |
|
Articles in Press |
|
2020-07-04 03:58 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-07-07 23:57 |
|
Typeset the Manuscript |
|
2020-07-21 17:16 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345